Medical therapy for obesity--current status and future hopes
- PMID: 17964918
- DOI: 10.1016/j.mcna.2007.06.013
Medical therapy for obesity--current status and future hopes
Abstract
In accepting any new drug for the treatment of obesity, the safety profile must make it acceptable for almost everyone. Criteria for selecting treatments involve evaluating the risks to the individual from obesity and balancing that against any possible problems with the treatment. Obesity is a chronic disease that has many causes. Cure is rare and treatment is thus aimed at palliation, that is, producing and maintaining weight loss. Wherever the primary site of action may be, however, the net effect must be a reduction in food intake or an increase in energy expenditure.
Similar articles
-
Medications for weight reduction.Endocrinol Metab Clin North Am. 2008 Dec;37(4):923-42. doi: 10.1016/j.ecl.2008.08.004. Endocrinol Metab Clin North Am. 2008. PMID: 19026940 Review.
-
A critical review of the cannabinoid receptor as a drug target for obesity management.Obes Rev. 2009 Jan;10(1):58-67. doi: 10.1111/j.1467-789X.2008.00520.x. Epub 2008 Aug 20. Obes Rev. 2009. PMID: 18721231 Review.
-
New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier?Pharmacol Biochem Behav. 2010 Nov;97(1):63-83. doi: 10.1016/j.pbb.2010.07.020. Epub 2010 Aug 3. Pharmacol Biochem Behav. 2010. PMID: 20688100 Review.
-
Effective obesity treatments.Am Psychol. 2007 Apr;62(3):234-46. doi: 10.1037/0003-066X.62.3.234. Am Psychol. 2007. PMID: 17469901 Review.
-
Challenges in the discovery and development of new agents for the treatment of obesity.Clin Pharmacol Ther. 2007 May;81(5):753-5. doi: 10.1038/sj.clpt.6100161. Epub 2007 Mar 21. Clin Pharmacol Ther. 2007. PMID: 17377527 Review.
Cited by
-
Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.Endocrine. 2013 Dec;44(3):583-90. doi: 10.1007/s12020-013-9971-5. Epub 2013 Apr 27. Endocrine. 2013. PMID: 23625194 Review.
-
Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.CNS Drugs. 2009 Dec;23(12):1003-21. doi: 10.2165/11530020-000000000-00000. CNS Drugs. 2009. PMID: 19958039 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical